Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast - PubMed (original) (raw)
Affiliations
- PMID: 10353737
Comparative Study
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast
L F Brown et al. Clin Cancer Res. 1999 May.
Abstract
The generation of vascular stroma is essential for solid tumor growth and involves stimulatory and inhibiting factors as well as stromal components that regulate functions such as cellular adhesion, migration, and gene expression. In an effort to obtain a more integrated understanding of vascular stroma formation in breast carcinoma, we examined expression of the angiogenic factor vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF); the VPF/VEGF receptors flt-1 and KDR; thrombospondin-1, which has been reported to inhibit angiogenesis; and the stromal components collagen type I, total fibronectin, ED-A+ fibronectin, versican, and decorin by mRNA in situ hybridization on frozen sections of 113 blocks of breast tissue from 68 patients including 28 sections of breast tissue without malignancy, 18 with in situ carcinomas, 56 with invasive carcinomas, and 8 with metastatic carcinomas. A characteristic expression profile emerged that was remarkably similar in invasive carcinoma, carcinoma in situ, and metastatic carcinoma, with the following characteristics: strong tumor cell expression of VPF/VEGF; strong endothelial cell expression of VPF/VEGF receptors; strong expression of thrombospondin-1 by stromal cells and occasionally by tumor cells; and strong stromal cell expression of collagen type I, total fibronectin, ED-A+ fibronectin, versican, and decorin. The formation of vascular stroma preceded invasion, raising the possibility that tumor cells invade not into normal breast stroma but rather into a richly vascular stroma that they have induced. Similarly, tumor cells at sites of metastasis appear to induce the vascular stroma in which they grow. We conclude that a distinct pattern of mRNA expression characterizes the generation of vascular stroma in breast cancer and that the formation of vascular stroma may play a role not only in growth of the primary tumor but also in invasion and metastasis.
Similar articles
- Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF. Guidi AJ, et al. Cancer. 1996 Aug 1;78(3):454-60. doi: 10.1002/(SICI)1097-0142(19960801)78:3<454::AID-CNCR12>3.0.CO;2-Y. Cancer. 1996. PMID: 8697391 - Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
Lee AH, Dublin EA, Bobrow LG, Poulsom R. Lee AH, et al. J Pathol. 1998 Aug;185(4):394-401. doi: 10.1002/(SICI)1096-9896(199808)185:4<394::AID-PATH117>3.0.CO;2-S. J Pathol. 1998. PMID: 9828838 - Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF. Brown LF, et al. Cancer Res. 1993 Oct 1;53(19):4727-35. Cancer Res. 1993. PMID: 8402650 - Vascular permeability factor, tumor angiogenesis and stroma generation.
Senger DR, Brown LF, Claffey KP, Dvorak HF. Senger DR, et al. Invasion Metastasis. 1994-1995;14(1-6):385-94. Invasion Metastasis. 1994. PMID: 7544775 Review. - Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
Mueller MM, Fusenig NE. Mueller MM, et al. Differentiation. 2002 Dec;70(9-10):486-97. doi: 10.1046/j.1432-0436.2002.700903.x. Differentiation. 2002. PMID: 12492491 Review.
Cited by
- Breast Cancer Stem Cells Upregulate IRF6 in Stromal Fibroblasts to Induce Stromagenesis.
Muralidharan H, Hansen T, Steinle A, Schumacher D, Stickeler E, Maurer J. Muralidharan H, et al. Cells. 2024 Aug 31;13(17):1466. doi: 10.3390/cells13171466. Cells. 2024. PMID: 39273037 Free PMC article. - The covert symphony: cellular and molecular accomplices in breast cancer metastasis.
Si H, Esquivel M, Mendoza Mendoza E, Roarty K. Si H, et al. Front Cell Dev Biol. 2023 Jun 27;11:1221784. doi: 10.3389/fcell.2023.1221784. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37440925 Free PMC article. Review. - Hypoxia: molecular pathophysiological mechanisms in human diseases.
Della Rocca Y, Fonticoli L, Rajan TS, Trubiani O, Caputi S, Diomede F, Pizzicannella J, Marconi GD. Della Rocca Y, et al. J Physiol Biochem. 2022 Nov;78(4):739-752. doi: 10.1007/s13105-022-00912-6. Epub 2022 Jul 23. J Physiol Biochem. 2022. PMID: 35870078 Free PMC article. Review. - Novel Drugs with High Efficacy against Tumor Angiogenesis.
Qi S, Deng S, Lian Z, Yu K. Qi S, et al. Int J Mol Sci. 2022 Jun 22;23(13):6934. doi: 10.3390/ijms23136934. Int J Mol Sci. 2022. PMID: 35805939 Free PMC article. Review. - The Role of Extracellular Matrix Proteins in Breast Cancer.
Lepucki A, Orlińska K, Mielczarek-Palacz A, Kabut J, Olczyk P, Komosińska-Vassev K. Lepucki A, et al. J Clin Med. 2022 Feb 25;11(5):1250. doi: 10.3390/jcm11051250. J Clin Med. 2022. PMID: 35268340 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous